Call for applications for a clinical trial in acquired coagulopathy
NHSBT funds clinical trials and studies of blood components and alternative strategies in patients who may need transfusion support.
We now invite calls in the area of acquired coagulopathy in any clinical setting where replacement therapy is currently given.
Studies to test novel diagnostic markers are also welcome. The indicative budget is £200,000 per year for up to 4 years.
Applications for prelimary/pilot studies are acceptable.
There will be a two-stage application process. The first, preliminary, application stage has now closed.
Selection Board shortlisting: 5th October 2016
Short-listed applicants notified and sent full application form: 10th October 2016
Deadline for full applications: 12th December 2016
Revisions and responses to reviewer comments: 7th March - 4th April 2017
R&D Committee meeting - funding decision made: 1st June 2017
For further information please contact Dr Nick Watkins, Assistant Director, Research and Development at